All Type of News
Amlopidine market steams up
The domestic amlodipine market is set to heat up as Kukje Pharm and Hyundai Pharm is rushing into the game to bite a bigger pie.
Following the country's No. 1 amlodipine forerunner Pfizer Korea, Hanmi Pharm hit its...
Zydena is under phase 2 clinical studies for portal hypertensionDong-A PharmTech Co., affiliate of Dong-A Pharmaceutical. Co., announced on February 25 that it has initiated a 200 patient, phase 2 clinical study in Europe to investigate the ...
|
Drug makers face probe over small package system
The Korea Food and Drug Administration unveiled its plan to scrutinize the country's pharmaceutical firms in relation to their uncooperative attitude involving small packets of medicine.
KFDA officials said the adm...
Novartis Korea names new presidentNovartis Koreas named Dr. Peter Jager as its new president as of March 1.
Jager, who has been the director of Novatis International AG, will replace Dr. Andrin Oswald who was...
|
Ildong cements ties with Japan's Shionoi
Ildong Pharm has forged its stronger alliance with Japan's leading drug maker Shionogi Co.
Under the agreement, Idong plans to distribute Shionogi's Finibax injection (doripenem hydrate) in 2010 on an exclusive bas...
Health ministry mulls designation of digestives as quasi-drugs
The Ministry of Health and Welfare is considering expanding the scope of quasi-drugs to digestives and preparations for intestinal flora.
In response to some proposals by the presidential transition committee and a...
Civic group calls for OTC selling at supermarkets
The government should allow supermarkets to sell OTC products, including digestives, analgesics and antipyretics, according to the Citizens' Coalition for Economic Justice.
In a statement, the civic group noted pro...
Pharmacists in Seoul to seek profitable business
A Seoul chapter of the Korean Pharmaceutical Association said it will focus on developing new earning sources of pharmacy and strengthening its management capabilities this year.
Seoul chapter chairman Cho Chan-whi...
SK, LG to get Korea's new drug development and technology awards
SK Chemicals, which developed an anti-impotence medicine M-vix will receive the Grand Prize in Korea New Drug Development Awards to be hosted by the Korean Drug Research Association (KDRA) and technology prize at the ...
Hanmi Chairman Lim named Asia's Best CEO
Hanmi Pharm Chairman Lim Sung-ki was nominated Asia's Best CEO from Institutional Investor magazine.
In a ceremony held in Hanmi Headquarters in Seoul, Lim was given the CEO honor in the healthcare and pharmaceutic...
